FDA Clears 79 First Generics In 2002 During Record-Breaking Year For ANDAs
Executive Summary
Generic versions of Glucophage (metformin), Accutane (isotretinoin) and Augmentin (amoxicillin/clavulanate) head a record-breaking year for first generic approvals by FDA
You may also be interested in...
Teva’s Generic Remeron Exclusivity Cut To Five Months By FDA Rules
Teva's generic Remeron (mirtazapine) will have only five months of marketing exclusivity from its approval date due to FDA's current interpretation of the trigger for first-to-file 180-day marketing exclusivity under the Waxman/Hatch Act, Teva reported in its Feb. 18 earnings teleconference
Teva’s Generic Remeron Exclusivity Cut To Five Months By FDA Rules
Teva's generic Remeron (mirtazapine) will have only five months of marketing exclusivity from its approval date due to FDA's current interpretation of the trigger for first-to-file 180-day marketing exclusivity under the Waxman/Hatch Act, Teva reported in its Feb. 18 earnings teleconference
Apotex Paxil Generics Earliest Launch Date Could Be September 2003
Apotex' earliest potential launch date for its generic version of GSK's Paxil is September 2003